glutathione kidneys Kidney tissue antioxidant enzyme activities and Glutathione Metabolism in Renal Cell

2023 Oct 31;43(10):BSR20230374

Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product

*Correspondence: Antonio Di Sabatino, [email protected] This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

This article provides a summary of the pharmacological effects of GLP1-based medicines for treatment of obesity-associated complications

I'll be following tomorrow's PCAC meeting as additional peptides are discussed, and it'll be interesting to see how those recommendations compare